Alterations made to measure

How Synthego’s CRISPR-edited cell products could simplify, accelerate R&D

Taking its gene editing services a step farther than other service providers that offer CRISPR editing tools and standard pre-edited cell lines, Synthego Corp. launched a portfolio of customized CRISPR-edited cell products. The new offering advances its goal of simplifying and accelerating research and drug development that relies on the technology.

Synthego launched its first

Read the full 548 word article

User Sign In